19/06/2019 - 13:59

MGC enters Brazilian medical cannabis market

19/06/2019 - 13:59

Bookmark

Save articles for future reference.

ASX-listed medical cannabis player, MGC Pharmaceuticals has extended its reach to Brazil after signing a three-year exclusive distribution agreement with ONIX Empreendimentos e Participações. Brazil is a key emerging market with specialist market insight provider, Prohibition Partners, estimating that the Brazilian and Latin American medical cannabis sector could be worth up to USD$8.5 billion by 2028.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options